(Q43593944)

25 November 2017

title

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder (English)

1 reference

25 November 2017

1 reference

Girdler SS

1

1 reference

25 November 2017

Straneva PA

2

1 reference

25 November 2017

Light KC

3

1 reference

25 November 2017

Pedersen CA

4

1 reference

25 November 2017

Morrow AL

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

published in

Biological Psychiatry

1 reference

25 November 2017

volume

49

1 reference

25 November 2017

issue

9

1 reference

25 November 2017

page(s)

788-797

1 reference

Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Molecular and functional adaptation of the GABA(A) receptor complex during pregnancy and after delivery in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Perceptual and coping processes across the menstrual cycle: an investigation in a premenstrual syndrome clinic and a community sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Relationship between symptom severity and hormone changes in women with premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Response to flumazenil in women with premenstrual dysphoric disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Effects of antidepressant treatment on neuroactive steroids in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Cortisol response to dexamethasone in women with premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Overview: toward a dysregulation hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Arousal and stress response across the menstrual cycle in women with three perimenstrual symptom patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Preliminary evidence for plasma adrenocorticotropin levels as biological correlates of premenstrual symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Menstrual cycle and premenstrual syndrome: modifiers of cardiovascular reactivity in women

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901044-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)01044-1

1 reference

25 November 2017

1 reference